Meta-Analysis Plan for 207581: Comparing the efficacy of 300 mg single dose tafenoquine with 14-day primaquine 15 mg treatment regimen for the prevention of P. vivax relapse: a non-inferiority analysis, Trial ID 208793

Meta-Analysis Plan for 207581: Comparing the efficacy of 300 mg single dose tafenoquine with 14-day primaquine 15 mg treatment regimen for the prevention of P. vivax relapse: a non-inferiority analysis, Trial ID 208793 | GSK